Posted Feb. 10, 2014 at 7:45 a.m.

Premium Lock NephroGenex: Biggest investor could own 49% of shares after IPO

Published: 2014-02-10 07:45:00
Updated: 2014-02-10 07:45:00

Nephrogenex's Pyridorin Nephrogenex's Pyridorin Image 1 of 2 · Next Image…

The Research Triangle Park company plans to offer 3.1 million shares in its IPO, priced in the range of $12 to $14 per share, according to the latest updated registration statement filed with the Securities and Exchange Commission. And one big investor could end up owning nearly half the shares....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll